Balber T, Tran L, Bencurova K, Raitanen J, Egger G, Mitterhauser M
Pharmaceuticals (Basel). 2022; 15(2).
PMID: 35215337
PMC: 8878163.
DOI: 10.3390/ph15020227.
Srivastava A, Kumar S, Ramaswamy R
BMC Syst Biol. 2014; 8:81.
PMID: 24997799
PMC: 4105126.
DOI: 10.1186/1752-0509-8-81.
Eisenach P, Soeth E, Roder C, Kloppel G, Tepel J, Kalthoff H
Br J Cancer. 2013; 109(3):694-703.
PMID: 23839495
PMC: 3738143.
DOI: 10.1038/bjc.2013.363.
Charoentong P, Angelova M, Efremova M, Gallasch R, Hackl H, Galon J
Cancer Immunol Immunother. 2012; 61(11):1885-903.
PMID: 22986455
PMC: 3493665.
DOI: 10.1007/s00262-012-1354-x.
Toiyama Y, Inoue Y, Yasuda H, Saigusa S, Yokoe T, Okugawa Y
J Gastroenterol. 2010; 46(2):153-63.
PMID: 20824289
DOI: 10.1007/s00535-010-0318-1.
Gene- and evidence-based candidate gene selection for schizophrenia and gene feature analysis.
Sun J, Han L, Zhao Z
Artif Intell Med. 2009; 48(2-3):99-106.
PMID: 19944577
PMC: 2826526.
DOI: 10.1016/j.artmed.2009.07.009.
A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case.
Sun J, Jia P, Fanous A, Webb B, van den Oord E, Chen X
Bioinformatics. 2009; 25(19):2595-6602.
PMID: 19602527
PMC: 2752609.
DOI: 10.1093/bioinformatics/btp428.
Stochastic noise in splicing machinery.
Melamud E, Moult J
Nucleic Acids Res. 2009; 37(14):4873-86.
PMID: 19546110
PMC: 2724286.
DOI: 10.1093/nar/gkp471.
MethCancerDB--aberrant DNA methylation in human cancer.
Lauss M, Visne I, Weinhaeusel A, Vierlinger K, Noehammer C, Kriegner A
Br J Cancer. 2008; 98(4):816-7.
PMID: 18253128
PMC: 2259180.
DOI: 10.1038/sj.bjc.6604219.
High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders.
Vernes S, Spiteri E, Nicod J, Groszer M, Taylor J, Davies K
Am J Hum Genet. 2007; 81(6):1232-50.
PMID: 17999362
PMC: 2276341.
DOI: 10.1086/522238.
caCORE version 3: Implementation of a model driven, service-oriented architecture for semantic interoperability.
Komatsoulis G, Warzel D, Hartel F, Shanbhag K, Chilukuri R, Fragoso G
J Biomed Inform. 2007; 41(1):106-23.
PMID: 17512259
PMC: 2254758.
DOI: 10.1016/j.jbi.2007.03.009.
MutationView/KMcancerDB: a database for cancer gene mutations.
Shimizu N, Ohtsubo M, Minoshima S
Cancer Sci. 2007; 98(3):259-67.
PMID: 17233812
PMC: 11159931.
DOI: 10.1111/j.1349-7006.2007.00405.x.
Evidence that public database records for many cancer-associated genes reflect a splice form found in tumors and lack normal splice forms.
Roy M, Xu Q, Lee C
Nucleic Acids Res. 2005; 33(16):5026-33.
PMID: 16147986
PMC: 1201329.
DOI: 10.1093/nar/gki792.
WebGestalt: an integrated system for exploring gene sets in various biological contexts.
Zhang B, Kirov S, Snoddy J
Nucleic Acids Res. 2005; 33(Web Server issue):W741-8.
PMID: 15980575
PMC: 1160236.
DOI: 10.1093/nar/gki475.
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
Gerhard D, Wagner L, Feingold E, Shenmen C, Grouse L, Schuler G
Genome Res. 2004; 14(10B):2121-7.
PMID: 15489334
PMC: 528928.
DOI: 10.1101/gr.2596504.
Kallikrein gene downregulation in breast cancer.
Yousef G, Yacoub G, Polymeris M, Popalis C, Soosaipillai A, Diamandis E
Br J Cancer. 2004; 90(1):167-72.
PMID: 14710225
PMC: 2395319.
DOI: 10.1038/sj.bjc.6601451.
The novel human MOST-1 (C8orf17) gene exhibits tissue specific expression, maps to chromosome 8q24.2, and is overexpressed/amplified in high grade cancers of the breast and prostate.
Tan J, Tock E, Chow V
Mol Pathol. 2003; 56(2):109-15.
PMID: 12665628
PMC: 1187302.
DOI: 10.1136/mp.56.2.109.
A computational/functional genomics approach for the enrichment of the retinal transcriptome and the identification of positional candidate retinopathy genes.
Katsanis N, Worley K, Gonzalez G, Ansley S, Lupski J
Proc Natl Acad Sci U S A. 2002; 99(22):14326-31.
PMID: 12391299
PMC: 137883.
DOI: 10.1073/pnas.222409099.
